Warning This job advert has expired and applications have closed.

Associate Practitioner | Barts Health NHS Trust

Posting date:	18 June 2024
Salary:	Not specified
Additional salary information:	£30,279 - £33,116 per annnum inc.
Hours:	Full time
Closing date:	18 July 2024
Location:	London, E1 2ES
Company:	Barts Health NHS Trust
Job type:	Permanent
Job reference:	6404476/259-6404476ESEL

Summary

An excitingopportunity has arisen for eligible staff working within the ESEL Partnership to undertake theIBMS Registration Portfolio and apply for the IBMS Certificate of Competence.

Successful Band 4 candidates will be based at a named laboratory, Royal London Hospital, but work flexibly across different teams and partnered laboratories. Predominately focused on Point of care testing but attainment of IBMS Certificate of Competence may require working in core and specialist laboratory sections.



To support the clinical services of the Trust and meeting the needs of our patients, participation in the Agenda for change shift pattern is required

The purpose of the NHS East and South East London Pathology Partnership (ESEL) is to provide patients with a high-quality, cost-effective service, and ensure the longer-term sustainability of NHS pathology services in east and south east London.



We are a new organisation, jointly owned by Barts Health NHS Trust, Homerton University Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust. Set up as an arms-length organisation, hosted by Barts Health NHS Trust, we have our own board and governance, with each of the three trusts having an equal voice and vote in the running of the Pathology Partnership. One of the largest pathology providers in the NHS, the Pathology Partnership brings together the strengths of teams from each of the three trusts into a single organisation, dedicated to the provision of pathology.



The NHS East and South East London Pathology Partnership  is an arms-length organisation providing pathology services to Barts Health NHS Trust, Homerton University Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust.  The Pathology Partnership is hosted by Barts Health.


The Pathology Partnership is based on well-established models for pathology networks, with the Royal London Hospital becoming the main hub laboratory for the network and Essential Service Laboratories (ESL) as a minimum at all other Hospital sites.


Pathology is made up of the following services - Blood Sciences including Haematology, Blood Transfusion and Biochemistry; Infectious Diseases including Microbiology and Virology; Cellular Pathology including Histopathology, non-gynae Cytology and mortuary services; Immunology; Cytogenetics and Molecular Haematology; Immunophenotyping; Clinical Transplantation and Retinoblastoma.  


The 2020/21 total operating costs across the Partnership were c. £126m per annum with a workforce establishment of circa. 822 WTE.  We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.


We particularly welcome applications from Black, Asian and minority ethnic candidates as they are underrepresented within Barts Health at this band.


The laboratory at RLH is equipped with Cobas 8000(Roche diagnostics) instruments which are connected to an integrated automated workflow solution, c8100 and p701(Roche diagnostics).



The specialist clinical chemistry work areas are equipped with D-100 (Biorad Laboratories), Ultimate 3000 (Thermo Scientific), Acquity UPLC (Waters), AAnalyst 800 (Perkin Elmer), Indiko Plus (Thermo Scientific), Capillarys (Sebia), Hydrasys (Sebia) and SPA plus (Binding site).



The Point of care testing portfolio includes AQT90 (Radiometer), ABL90 Flex (Radiometer), ABL800 series (Radiometer), Clinitek Status (Siemens), i-Stat1 (Abbott), i-Stat Alinity (Abbott), Freestyle Precision Pro (Abbott), Accuchek Informa II (Roche diagnostics) and DCA Vantage (Siemens).



All staff identified as AT-RISK who meet the requirements of the post will be prioritised accordingly. Priority will initially be given to Barts Health employees. This does not apply to Comprehensive Local Research Network (CLRN) roles.

As an Equal Opportunities Employer we actively support applications from individuals’ who apply under the Guaranteed Interview Scheme and will process your application as appropriate. To demonstrate our commitment we use the disability symbols on NHS Jobs.

We reserve the right to expire vacancies prior to the advertised closing date once a sufficient number of applications has been received and we regret that we are unable to provide notification if your application is unsuccessful.

All new appointments (excluding all Medical & Dental doctors) are subject to 6 months’ probation period.

In submitting an application form, you authorise Barts Health to confirm any previous NHS service details via the Electronic Staff Record Inter Authority Transfer process should you be appointed to the post.

All vacancies followed by INTERNAL ONLY, have been classified as an internal role and only internal candidates will be considered.

If you are successful at the shortlisting stage we will contact you via NHS Jobs e-Mail and text message with details of your interview. Please continue to check your e-Mails and also your NHS Jobs account for correspondence.

Barts Health is committed to safeguarding the welfare of children and to child protection. The Trust aims to ensure as far as is possible that anyone, paid or unpaid, who seeks to work in our organisation and who gains access to children, is safe to do so.

If you require further information or would like to arrange an informal visit please contact

Greg Dearman, Biochemistry Scientific Lead: 0203 246 0443

(greg.dearman@nhs.net)



The full job description provides an overview of the key tasks and responsibilities of the role, and the person specification outlines the qualifications, skills, experience, and knowledge required. For both documents, please view the attachment/s below.


This advert closes on Tuesday 2 Jul 2024